For example, a recent report demonstrated that a novel CAR can selectively and specifically target the cell surface complex of the specific liver cancer marker alpha-fetoprotein (AFP) derived AFP158–166 peptide and HLA-A*02:01 [88]. This evidence concerns the gene AFP and liver cancer.